LSD1 Antibody Market Applications
Applications across therapeutic areas define the LSD1 Antibody Market landscape. Cancer research dominates with 45% market share, valued at USD 450 million in 2024 and projected to reach USD 1.05 billion by 2035. LSD1 inhibitors show particular promise in acute myeloid leukemia and small cell lung cancer, where epigenetic dysregulation drives disease pathology. Neurological disorders represent...
0 Comments 0 Shares 6 Views 0 Reviews